Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Phase I trial of alpha-difluoromethyl ornithine (DFMO) and methylglyoxal bis (guanylhydrazone) (MGBG) in patients with advanced prostatic cancer.

Phase I trial of alpha-difluoromethyl ornithine (DFMO) and methylglyoxal bis (guanylhydrazone)... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Urology Pubmed

Phase I trial of alpha-difluoromethyl ornithine (DFMO) and methylglyoxal bis (guanylhydrazone) (MGBG) in patients with advanced prostatic cancer.

Herr, H W; Warrel, R P; Burchenal, J H
Urology , Volume 28 (6): 4 – Jan 20, 1987
Download PDF

Phase I trial of alpha-difluoromethyl ornithine (DFMO) and methylglyoxal bis (guanylhydrazone) (MGBG) in patients with advanced prostatic cancer.

Herr, H W; Warrel, R P; Burchenal, J H
Urology , Volume 28 (6): 4 – Jan 20, 1987

Loading next page...
 
/lp/pubmed/phase-i-trial-of-alpha-difluoromethyl-ornithine-dfmo-and-methylglyoxal-ktKKWWOR5G

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
0090-4295
DOI
10.1016/0090-4295(86)90154-8
pmid
3097903

Abstract

Journal

Urology – Pubmed

Published: Jan 20, 1987

There are no references for this article.